NO963848L - Method for diagnosing and treating HIV-1 infection - Google Patents
Method for diagnosing and treating HIV-1 infectionInfo
- Publication number
- NO963848L NO963848L NO963848A NO963848A NO963848L NO 963848 L NO963848 L NO 963848L NO 963848 A NO963848 A NO 963848A NO 963848 A NO963848 A NO 963848A NO 963848 L NO963848 L NO 963848L
- Authority
- NO
- Norway
- Prior art keywords
- diagnosing
- infection
- treating hiv
- hiv
- treating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Rheumatology (AREA)
- Rehabilitation Therapy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21374394A | 1994-03-14 | 1994-03-14 | |
PCT/US1995/003236 WO1995025124A1 (en) | 1994-03-14 | 1995-03-13 | Methods to diagnose and treat hiv-1 infection |
Publications (2)
Publication Number | Publication Date |
---|---|
NO963848D0 NO963848D0 (en) | 1996-09-13 |
NO963848L true NO963848L (en) | 1996-11-14 |
Family
ID=22796323
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO963848A NO963848L (en) | 1994-03-14 | 1996-09-13 | Method for diagnosing and treating HIV-1 infection |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0750636A1 (en) |
JP (1) | JPH10504798A (en) |
CA (1) | CA2185129A1 (en) |
FI (1) | FI963638A (en) |
NO (1) | NO963848L (en) |
WO (1) | WO1995025124A1 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1141314A2 (en) | 1998-12-31 | 2001-10-10 | Chiron Corporation | Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
AU2002320314A1 (en) | 2001-07-05 | 2003-01-21 | Chiron, Corporation | Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
PT1425295E (en) * | 2001-09-06 | 2010-03-24 | Centre Nat Rech Scient | Modified peptides and their use for the treatment of autoimmune diseases |
CN101588813A (en) * | 2005-04-12 | 2009-11-25 | 杜克大学 | Method of inducing neutralizing antibodies to human immunodeficiency virus |
AU2006235507B2 (en) * | 2005-04-12 | 2012-08-30 | Duke University | Method of inducing neutralizing antibodies to human immunodeficiency virus |
CA2683752A1 (en) | 2007-04-13 | 2008-10-23 | Duke University | Method of inducing neutralizing antibodies to human immunodeficiency virus |
EP2413951A4 (en) | 2009-04-03 | 2015-05-20 | Univ Duke | COMPOSITION CAPABLE OF INDUCING THE PRODUCTION OF VERY REACTIVE NEUTRALIZING ANTIBODIES AGAINST HIV |
US10076567B2 (en) | 2013-09-27 | 2018-09-18 | Duke University | MPER-liposome conjugates and uses thereof |
US10213482B2 (en) | 2014-12-12 | 2019-02-26 | Immupharma France Sa | Methods of treating chronic inflammatory diseases |
-
1995
- 1995-03-13 CA CA002185129A patent/CA2185129A1/en not_active Abandoned
- 1995-03-13 WO PCT/US1995/003236 patent/WO1995025124A1/en not_active Application Discontinuation
- 1995-03-13 EP EP95914049A patent/EP0750636A1/en not_active Withdrawn
- 1995-03-13 JP JP7524156A patent/JPH10504798A/en not_active Ceased
-
1996
- 1996-09-13 NO NO963848A patent/NO963848L/en not_active Application Discontinuation
- 1996-09-13 FI FI963638A patent/FI963638A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0750636A1 (en) | 1997-01-02 |
WO1995025124A1 (en) | 1995-09-21 |
FI963638A (en) | 1996-11-13 |
AU694204B2 (en) | 1998-07-16 |
CA2185129A1 (en) | 1995-09-21 |
FI963638A0 (en) | 1996-09-13 |
JPH10504798A (en) | 1998-05-12 |
AU2120595A (en) | 1995-10-03 |
NO963848D0 (en) | 1996-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR960008976A (en) | Treatment device and treatment method | |
NO970532D0 (en) | System and method of blood treatment | |
NO980687L (en) | System and method for perfusion hyperthermia treatment | |
NO973836D0 (en) | Benzopyran-containing compounds and process for their use | |
FI973378A (en) | Apparatus and method | |
NO933743L (en) | Method and System for Performing Endoscope Surgery | |
KR970700962A (en) | METHOD AND APPARATUS FOR MULTIUSER-INTERFERENCE REDUCTION | |
DE69612411D1 (en) | Underwater treatment process and system | |
DE59807358D1 (en) | Process diagnostic system and method | |
BR9510353A (en) | Wastewater treatment plant and method | |
NO970543D0 (en) | Method and system for predicting blood treatment parameters | |
NO963416L (en) | Method and apparatus for gas treatment | |
NO965489D0 (en) | Controlled denitrification process and system | |
DE69609959D1 (en) | EXHAUST TREATMENT | |
DE69424640D1 (en) | Film treatment method and system | |
ID17194A (en) | INFLAMATION TREATMENT METHOD | |
DE69515626D1 (en) | Plasma treatment method and device | |
DE69631282D1 (en) | BLOOD PROCESSING SYSTEM AND METHOD | |
KR960016661A (en) | Apparatus having peak-shaped dam and manufacturing method thereof | |
EE9600094A (en) | Wastewater treatment method and equipment | |
DE69514960D1 (en) | Slag treatment system and method | |
DE69536034D1 (en) | Exposure apparatus and exposure method | |
NO963848L (en) | Method for diagnosing and treating HIV-1 infection | |
DK0865609T3 (en) | Method for diagnosis and treatment of squamous cell carcinoma | |
NO963366D0 (en) | Peptides and method of treating diabetes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |